DNA copy number aberrations and disruption of the p16ink4a/rb pathway in radiation-induced and spontaneous rat mammary carcinomas

Radiation Research

Volumn 174, Issue 2, 2010, Pages 206-215

  Iizuka, Daisuke ^a,b   Imaoka, Tatsuhiko ^a   Takabatake, Takashi ^a   Nishimura, Mayumi ^a   Kakinuma, Shizuko ^a   Nishimura, Yukiko ^a   Shimada, Yoshiya ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MESSENGER RNA; PROTEIN P19ARF; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; DNA; PRIMER DNA; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CHROMOSOME 10; CHROMOSOME 1Q; CHROMOSOME 4; CHROMOSOME ABERRATION; CHROMOSOME PAIRING; COPY NUMBER VARIATION; DOWN REGULATION; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE DISRUPTION; GENE MUTATION; IONIZING RADIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TRISOMY; UPREGULATION; ANIMAL; BREAST TUMOR; DNA MICROARRAY; ENZYMOLOGY; EXPERIMENTAL MAMMARY NEOPLASM; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENETIC TRANSCRIPTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; PROTO ONCOGENE; RADIATION RESPONSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCINTISCANNING;

ANIMALS; BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PRIMERS; DNA, NEOPLASM; DOWN-REGULATION; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MAMMARY NEOPLASMS, ANIMAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENES; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 77955146598     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR2006.1     Document Type: Article

References (41)

1. J. B. Little, Radiation carcinogenesis. Carcinogenesis 21, 397-404 (2000).
2. D. L. Preston, E. Ron, S. Tokuoka, S. Funamoto, N. Nishi, M. Soda, K. Mabuchi and K. Kodama, Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat. Res. 168, 1-64 (2007).
3. L. Huang, A. R. Snyder and W. F. Morgan, Radiation-induced genomic instability and its implications for radiation carcinogenesis. Oncogene 22, 5848-5854 (2003).
4. S. Kakinuma, M. Nishimura, S. Sasanuma, K. Mita, G. Suzuki, Y. Katsura, T. Sado and Y. Shimada, Spectrum of Znfn1a1 (Ikaros) inactivation and its association with loss of hetero-zygosity in radiogenic T-cell lymphomas in susceptible B6C3F1 mice. Radiat. Res. 157, 331-340 (2002).
5. M. Nakashima, N. Takamura, H. Namba, V. Saenko, S. Meirmanov, N. Matsumoto, T. Hayashi, S. Maeda and I. Sekine, RET oncogene amplification in thyroid cancer: correlations with radiation-associated and high-grade malignancy. Hum. Pathol. 38, 621-628 (2007).
6. Y. Wakabayashi, J. Inoue, Y. Takahashi, A. Matsuki, H. Kosugi-Okano, T. Shinbo, Y. Mishima, O. Niwa and R. Kominami, Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas. Biochem. Biophys. Res. Commun. 301, 598-603 (2003).
7. Y. Shimada, M. Nishimura, S. Kakinuma, M. Okumoto, T. Shiroishi, K. H. Clifton and S. Wakana, Radiation-associated loss of heterozygosity at the Znfn1a1 (Ikaros) locus on chromosome 11 in murine thymic lymphomas. Radiat. Res. 154, 293-300 (2000).
8. T. Paunesku, Y. Zhang, M. A. Gemmell and G. E. Woloschak, p53 gene deletions in paraffin-preserved lymphoid tumors from irradiated mice. Leuk. Res. 24, 511-517 (2000).
9. C. W. Miller, A. Aslo, C. Tsay, D. Slamon, K. Ishizaki, J. Toguchida, T. Yamamuro, B. Lampkin and H. P. Koeffler, Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res. 50, 7950-7954 (1990).
10. S. Miura, M. Nakashima, M. Ito, H. Kondo, S. Meirmanov, T. Hayashi, M. Soda, T. Matsuo and I. Sekine, Significance of HER2 and C-MYC oncogene amplifications in breast cancer in atomic bomb survivors: associations with radiation exposure and histologic grade. Cancer 112, 2143-2151 (2008).
11. E. H. van Beers and P. M. Nederlof, Array-CGH and breast cancer. Breast Cancer Res. 8, 210 (2006).
12. J. Climent, J. L. Garcia, J. H. Mao, J. Arsuaga and J. Perez-Losada, Characterization of breast cancer by array comparative genomic hybridization. Biochem. Cell Biol. 85, 497-508 (2007).
13. K. Unger, E. Malisch, G. Thomas, H. Braselmann, A. Walch, G. Jackl, P. Lewis, E. Lengfelder, T. Bogdanova and H. Zitzelsberger, Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTC. Oncogene 27, 4592-4602 (2008).
14. S. Nandi, R. C. Guzman and J. Yang, Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc. Natl. Acad. Sci. USA 92, 3650-3657 (1995).
15. T. Imaoka, M. Nishimura, D. Iizuka, K. Daino, T. Takabatake, M. Okamoto, S. Kakinuma and Y. Shimada, Radiation-induced mammary carcinogenesis in rodent models: what's different from chemical carcinogenesis? J. Radiat. Res. (Tokyo) 50, 281-293 (2009).
16. T. Imaoka, M. Nishimura, S. Kakinuma, Y. Hatano, Y. Ohmachi, S. Yoshinaga, A. Kawano, A. Maekawa and Y. Shimada, High relative biologic effectiveness of carbon ion radiation on induction of rat mammary carcinoma and its lack of H-ras and Tp53 mutations. Int. J. Radiat. Oncol. Biol. Phys. 69, 194-203 (2007).
17. T. Imaoka, M. Nishimura, Y. Nishimura, S. Kakinuma and Y. Shimada, Persistent cell proliferation of terminal end buds precedes radiation-induced rat mammary carcinogenesis. In Vivo 20, 353-358 (2006).
18. T. Imaoka, M. Nishimura, A. Teramoto, Y. Nishimura, M. Ootawara, H. Osada, S. Kakinuma, A. Maekawa and Y. Shimada, Cooperative induction of rat mammary cancer by radiation and 1-methyl-1-nitrosourea via the oncogenic pathways involving c-Myc activation and H-ras mutation. Int. J. Cancer 115, 187-193 (2005).
19. T. Imaoka, S. Yamashita, M. Nishimura, S. Kakinuma, T. Ushijima and Y. Shimada, Gene expression profiling distinguishes between spontaneous and radiation-induced rat mammary carcinomas. J. Radiat. Res. (Tokyo) 49, 349-360 (2008).
20. J. D. Haag, L. C. Hsu, M. A. Newton and M. N. Gould, Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis. Mol. Carcinog. 17, 134-143 (1996).
21. K. J. Livak and T. D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408 (2001).
22. A. Okamoto, D. J. Demetrick, E. A. Spillare, K. Hagiwara, S. P. Hussain, W. P. Bennett, K. Forrester, B. Gerwin, M. Serrano and D. H. Beach, Mutations and altered expression of p16INK4 in human cancer. Proc. Natl. Acad. Sci. USA 91, 11045-11049 (1994).
23. J. G. Herman, J. Jen, A. Merlo and S. B. Baylin, Hypermethylation- associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res. 56, 722-727 (1996).
24. M. Abe, E. Okochi, T. Kuramoto, A. Kaneda, T. Takato, T. Sugimura and T. Ushijima, Cloning of the 59 upstream region of the rat p16 gene and its role in silencing. Jpn. J. Cancer Res. 93, 1100-1106 (2002).
25. K. Honoki, T. Tsujiuchi, T. Mori, K. Yoshitani, M. Tsutsumi, Y. Takakura and Y. Mii, Expression of the p16INK4a gene and methylation pattern of CpG sites in the promoter region in rat tumor cell lines. Mol. Carcinog. 39, 10-14 (2004).
26. K. Milde-Langosch, A. M. Bamberger, G. Rieck, B. Kelp and T. Loning, Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype. Breast Cancer Res. Treat. 67, 61-70 (2001).
27. S. C. Wong, J. K. Chan, K. C. Lee and W. L. Hsiao, Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast. J. Pathol. 194, 35-42 (2001).
28. E. A. Dublin, N. K. Patel, C. E. Gillett, P. Smith, G. Peters and D. M. Barnes, Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histopathological parameters. Int. J. Cancer 79, 71-75 (1998).
29. V. G. Gorgoulis, E. N. Koutroumbi, A. Kotsinas, P. Zacharatos, C. Markopoulos, L. Giannikos, V. Kyriakou, Z. Voulgaris, I. Gogas and C. Kittas, Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas. Mol. Med. 4, 807-822 (1998).
30. A. T. Christian, E. G. Snyderwine and J. D. Tucker, Comparative genomic hybridization analysis of PhIP-induced mammary carcinomas in rats reveals a cytogenetic signature. Mutat. Res. 506-507, 113-119 (2002).
31. T. Adamovic, D. McAllister, V. Guryev, X. Wang, J. W. Andrae, E. Cuppen, H. J. Jacob and S. L. Sugg, Microalterations of inherently unstable genomic regions in rat mammary carcinomas as revealed by long oligonucleotide array-based comparative genomic hybridization. Cancer Res. 69, 5159-5167 (2009).
32. J. J. Li, S. J. Weroha, W. L. Lingle, D. Papa, J. L. Salisbury and S. A. Li, Estrogen mediates Aurora-A overexpression, centro-some amplification, chromosomal instability, and breast cancer in female ACI rats. Proc. Natl. Acad. Sci. USA 101, 18123-18128 (2004).
33. W. Chen, M. Salto-Tellez, N. Palanisamy, K. Ganesan, Q. Hou, L. K. Tan, L. H. Sii, K. Ito, B. Tan and P. Tan, Targets of genome copy number reduction in primary breast cancers identified by integrative genomics. Genes Chromosomes Cancer 46, 288-301 (2007).
34. W. Au, S. W. Soukup and T. I. Mandybur, Excess chromosome no.4 in ethylnitrosourea-induced neurogenic tumor lines of the rat. J. Natl. Cancer Inst. 59, 1709-1716 (1977).
35. A. Walentinsson, A. Sjoling, K. Helou, K. Klinga-Levan and G. Levan, Genomewide assessment of genetic alterations in DMBA-induced rat sarcomas: cytogenetic, CGH, and allelotype analyses reveal recurrent DNA copy number changes in rat chromosomes 1, 2, 4, and 7. Genes Chromosomes Cancer 28, 184-195 (2000).
36. G. Hodgson, J. H. Hager, S. Volik, S. Hariono, M. Wernick, D. Moore, N. Nowak, D. G. Albertson, D. Pinkel and J. W. Gray, Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat. Genet. 29, 459-464 (2001).
37. J. Silva, J. M. Silva, G. Dominguez, J. M. Garcia, B. Cantos, R. Rodriguez, F. J. Larrondo, M. Provencio, P. Espana and F. Bonilla, Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms. J. Pathol. 199, 289-297 (2003).
38. Y. Li, M. A. Nichols, J. W. Shay and Y. Xiong, Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res. 54, 6078-6082 (1994).
39. Y. Takasaki, Y. Yamada, K. Sugahara, T. Hayashi, N. Dateki, H. Harasawa, S. Kawabata, H. Soda, S. Ikeda and S. Kamihira, Interruption of p16 gene expression in adult T-cell leukaemia/lymphoma: clinical correlation. Br. J. Haematol. 122, 253-259 (2003).
40. S. C. Brownhill, C. Taylor and S. A. Burchill, Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT. Br. J. Cancer 96, 1914-1923 (2007).
41. A. Kuijper, R. A. de Vos, J. H. Lagendijk, E. van der Wall and P. J. van Diest, Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors. Am. J. Clin. Pathol. 123, 690-698 (2005).